ALK1 protein may play a role in breast cancer metastasis

Breast cancer patients with high levels of the protein activin-like receptor kinase (ALK1) in the blood vessels of their tumors were more likely to develop metastatic disease, research shows. This makes inhibition of the ALK1 pathway a possible new target for the treatment of metastatic breast cancer. (Mehr in: Cancer News — ScienceDaily)